Insulet PODD Accounts Payable

Accounts Payable at other companies

Eli LillyLLY

$6.11B+50.0%

Tandem Diabetes CareTNDM

$64.13M+14.9%

MedtronicMDT

$2.64B+8.0%

Beta BionicsBBNX

$5.35M+56.3%

Opko HealthOPK

$50.04M-11.7%

VAN

Vivani MedicalVANI

$1.47M+45.9%

FAQ

What is Insulet's accounts payable?

Insulet (PODD) reported accounts payable of $123.3M in Q2 2026.

How has Insulet's accounts payable changed year-over-year?

Insulet's accounts payable increased by 28.3% year-over-year, from $96.1M to $123.3M.

What is the long-term trend for Insulet's accounts payable?

Over 5 years (2020 to 2025), Insulet's accounts payable has grown at a 6.8% compound annual growth rate (CAGR), from $54.1M to $75M.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.